Showing results (1351-1360 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|August 18, 2026
Clinical Outcomes of HIF-2α inhibition in Von Hippel-Lindau Disease: A Multicenter Real-World StudyMousab Al Abbas, Jabra Zarka, Alvin C Silva, et al.
The Oncologist|September 22, 2026
Comparative safety of concurrent adjuvant trastuzumab emtansine versus trastuzumab with radiotherapy in HER2-positive early breast cancerMine Aysan, Bahadir Koylu, Ayberk Bayramgil, et al.
The Oncologist|September 10, 2026
A Secret-Shopper Study Evaluating Logistic Barriers to Care Among Young Adults with Acute Lymphoblastic LeukemiaSamuel Greenwald, Muna Hassan, Lori Muffly, et al.
The Oncologist|October 6, 2026
Global Disparities in the Availability and Reimbursement of Systemic Therapies for Renal Cell Carcinoma: Results of the International ARON-AID SurveyYuksel Urun, Kannan Sridharan, Anca Zgura, et al.
The Oncologist|October 14, 2026
A randomized phase II study of fulvestrant with or without ganetespib in patients with endocrine resistant metastatic breast cancerAlbert Grinshpun, Adrienne G Waks, Jingxin Fu, et al.
The Oncologist|October 8, 2026
Nivolumab and Cabozantinib in People with HIV and Advanced Solid Tumors: A Pilot Trial and Systematic ReviewHaiying Cheng, Ece Cali, Mumtu Lalla, et al.
The Oncologist|August 25, 2026
Phase 2 Study of Futibatinib in Combination with Pembrolizumab in Patients with FGF19 expressing Advanced Hepatocellular CarcinomaNguyen H Tran, Mathias E Palmer, Angela Ulrich, et al.
The Oncologist|September 3, 2026
CT-Derived Body Composition and Early Changes Predict Outcomes of First-Line Chemo-Immunotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaXia Gan, Zhengzheng Yu, Yaning Tang, et al.
The Oncologist|September 7, 2026
Real-world characteristics of trastuzumab deruxtecan-related interstitial lung disease in Japanese patients with breast cancer and gastric cancerYutaka Fujiwara, Katsunori Oikado, Tomohisa Baba, et al.
The Oncologist|October 1, 2026
Precision Oncology at Speed: Workflow Design Determines Clinical Utility in Rapid Molecular Testing for Lung CancerBrandon S Sheffield, Katherina Baranova, Parneet Cheema, et al.
Pageof 570